BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23369109)

  • 1. Effects of hypo- and hyperthyroidism on proliferation, angiogenesis, apoptosis and expression of COX-2 in the corpus luteum of female rats.
    Silva JF; Ocarino NM; Vieira AL; Nascimento EF; Serakides R
    Reprod Domest Anim; 2013 Aug; 48(4):691-8. PubMed ID: 23369109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteal activity of pregnant rats with hypo-and hyperthyroidism.
    Silva JF; Ocarino NM; Serakides R
    J Ovarian Res; 2014 Jul; 7():75. PubMed ID: 25298361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of corpus luteum angiogenesis in immature hypothyroid rdw rats after thyroxine treatment: morphologic and molecular evidence.
    Macchiarelli G; Palmerini MG; Nottola SA; Cecconi S; Tanemura K; Sato E
    Theriogenology; 2013 Jan; 79(1):116-26. PubMed ID: 23122683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome.
    Scotti L; Irusta G; Abramovich D; Tesone M; Parborell F
    Mol Cell Endocrinol; 2011 Mar; 335(2):116-25. PubMed ID: 21238536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis and vascular endothelial growth factor expression in the equine corpus luteum.
    Al-zi'abi MO; Watson ED; Fraser HM
    Reproduction; 2003 Feb; 125(2):259-70. PubMed ID: 12578540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal growth restriction in hypothyroidism is associated with changes in proliferative activity, apoptosis and vascularisation of the placenta.
    Silva JF; Vidigal PN; Galvão DD; Boeloni JN; Nunes PP; Ocarino NM; Nascimento EF; Serakides R
    Reprod Fertil Dev; 2012; 24(7):923-31. PubMed ID: 22935153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in plasma homocysteine levels of rats with experimentally induced hypothyroidism and hyperthyroidism.
    Ozkan Y; Dönder E; Güney H; Baydaş G
    Neuro Endocrinol Lett; 2005 Oct; 26(5):536-40. PubMed ID: 16264404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis in the human corpus luteum: changes in expression of angiopoietins in the corpus luteum throughout the menstrual cycle and in early pregnancy.
    Sugino N; Suzuki T; Sakata A; Miwa I; Asada H; Taketani T; Yamagata Y; Tamura H
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6141-8. PubMed ID: 16118339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of vascular endothelial growth factor and its receptors in the porcine corpus luteum during the estrous cycle and early pregnancy.
    Kaczmarek MM; Kowalczyk AE; Waclawik A; Schams D; Ziecik AJ
    Mol Reprod Dev; 2007 Jun; 74(6):730-9. PubMed ID: 17120307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular dynamics in relation to immunolocalisation of VEGF-A, VEGFR-2 and Ang-2 in the bovine corpus luteum.
    Hünigen H; Bisplinghoff P; Plendl J; Bahramsoltani M
    Acta Histochem; 2008; 110(6):462-72. PubMed ID: 18541291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular composition, apoptosis, and expression of angiogenic factors in the corpus luteum during prostaglandin F2alpha-induced regression in sheep.
    Vonnahme KA; Redmer DA; Borowczyk E; Bilski JJ; Luther JS; Johnson ML; Reynolds LP; Grazul-Bilska AT
    Reproduction; 2006 Jun; 131(6):1115-26. PubMed ID: 16735551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta-like ligand 4 regulates vascular endothelial growth factor receptor 2-driven luteal angiogenesis through induction of a tip/stalk phenotype in proliferating endothelial cells.
    García-Pascual CM; Zimmermann RC; Ferrero H; Shawber CJ; Kitajewski J; Simón C; Pellicer A; Gómez R
    Fertil Steril; 2013 Dec; 100(6):1768-76.e1. PubMed ID: 24074756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of hypo- or hyperthyroidism on ovarian function in Brahman cows.
    De Moraes GV; Vera-Avila HR; Lewis AW; Koch JW; Neuendorff DA; Hallford DM; Reeves JJ; Randel RD
    J Anim Sci; 1998 Mar; 76(3):871-9. PubMed ID: 9535350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The changing trends of expression of VEGF and its relationship with the levels of NO in rat corpus luteum of pseudopregnant].
    Zheng HL; Ni J; Bian SL
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2005 May; 21(2):227-30. PubMed ID: 21171350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis does not affect the vasculature of the corpus luteum of pregnancy in the rat.
    Arfuso F; Meyer GT
    Apoptosis; 2003 Dec; 8(6):665-71. PubMed ID: 14739612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF system expression in different stages of estrous cycle in the corpus luteum of non-treated and superovulated water buffalo.
    Papa PC; Moura CE; Artoni LP; Fátima LA; Campos DB; Marques JE; Baruselli PS; Binelli M; Pfarrer C; Leiser R
    Domest Anim Endocrinol; 2007 Nov; 33(4):379-89. PubMed ID: 17014980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological and immunohistochemical characterization of equine anovulatory haemorrhagic follicles (AHFs).
    Ellenberger C; Müller K; Schoon HA; Wilsher S; Allen WR
    Reprod Domest Anim; 2009 Jun; 44(3):395-405. PubMed ID: 18954391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preovulatory treatment of mice with anti-VEGF receptor 2 antibody inhibits angiogenesis in corpora lutea.
    Zimmermann RC; Hartman T; Bohlen P; Sauer MV; Kitajewski J
    Microvasc Res; 2001 Jul; 62(1):15-25. PubMed ID: 11421657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypo-and hyperthyroidism affect the ATP, ADP and AMP hydrolysis in rat hippocampal and cortical slices.
    Bruno AN; Diniz GP; Ricachenevsky FK; Pochmann D; Bonan CD; Barreto-Chaves ML; Sarkis JJ
    Neurosci Res; 2005 May; 52(1):61-8. PubMed ID: 15811553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulatory effects of eicosanoids on ovarian angiogenesis in early luteal phase in cyclooxygenase-2 inhibitor-treated rats.
    Sakurai T; Tamura K; Kogo H
    Eur J Pharmacol; 2005 Jun; 516(2):158-64. PubMed ID: 15921676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.